+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
52743-73-4,MFCD06653411
Catalog No.:AA00D81T

52743-73-4 | 1-Ethyl-5-oxopyrrolidine-3-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
1 week  
$245.00   $172.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00D81T
Chemical Name:
1-Ethyl-5-oxopyrrolidine-3-carboxylic acid
CAS Number:
52743-73-4
Molecular Formula:
C7H11NO3
Molecular Weight:
157.1671
MDL Number:
MFCD06653411
SMILES:
CCN1CC(CC1=O)C(=O)O
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
190  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.7  

Downstream Synthesis Route
845546-62-5    52743-73-4   
C32H41F2N3O6 
 
C32H41F2N3O6 

[1]Iserloh;Pan;Stamford;Kennedy;Zhang;Zhang;Parker;McHugh;Favreau;Strickland;Voigt[BioorganicandMedicinalChemistryLetters,2008,vol.18,#1,p.418-422]

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2530078,2012,A1

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2530078,2012,A1Locationinpatent:Page/Pagecolumn68

[2]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2021/219849,2021,A1Locationinpatent:Page/Pagecolumn172;173

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2015/180612,2015,A1Locationinpatent:Page/Pagecolumn64;65

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 52743-73-4
1363166-32-8

1363166-32-8

 16199-99-8

16199-99-8

 208118-23-4

208118-23-4

 30932-84-4

30932-84-4

 30948-17-5

30948-17-5

 64320-89-4

64320-89-4
Building Blocks
More >
Historical Records
862827-01-8

862827-01-8
Tags:52743-73-4 Molecular Formula|52743-73-4 MDL|52743-73-4 SMILES|52743-73-4 1-Ethyl-5-oxopyrrolidine-3-carboxylic acid
Catalog No.: AA00D81T
52743-73-4,MFCD06653411
52743-73-4 | 1-Ethyl-5-oxopyrrolidine-3-carboxylic acid
Pack Size： 500mg
Purity：
1 week
$245.00 $172.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00D81T
Chemical Name: 1-Ethyl-5-oxopyrrolidine-3-carboxylic acid
CAS Number: 52743-73-4
Molecular Formula: C7H11NO3
Molecular Weight: 157.1671
MDL Number: MFCD06653411
SMILES: CCN1CC(CC1=O)C(=O)O
Properties
Form: Solid  
Storage: Keep in dry area;2-8℃;  
Complexity: 190  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 1  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.7  
Downstream Synthesis Route
845546-62-5    52743-73-4   
C32H41F2N3O6 
 
C32H41F2N3O6 

[1]Iserloh;Pan;Stamford;Kennedy;Zhang;Zhang;Parker;McHugh;Favreau;Strickland;Voigt[BioorganicandMedicinalChemistryLetters,2008,vol.18,#1,p.418-422]

617-52-7    52743-73-4 

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2530078,2012,A1

100911-29-3    52743-73-4 

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2530078,2012,A1Locationinpatent:Page/Pagecolumn68

[2]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2021/219849,2021,A1Locationinpatent:Page/Pagecolumn172;173

97-65-4    75-04-7    52743-73-4 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2015/180612,2015,A1Locationinpatent:Page/Pagecolumn64;65

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Related Products of of 52743-73-4
1363166-32-8
1363166-32-8
16199-99-8
16199-99-8
208118-23-4
208118-23-4
30932-84-4
30932-84-4
30948-17-5
30948-17-5
64320-89-4
64320-89-4
Building Blocks More >
500770-76-3
500770-76-3
Boc-(s)-3-amino-3-(3-bromo-phenyl)-propionic acid
AA00D877 | MFCD03427924
503536-75-2
503536-75-2
2-Amino-5-(4-methoxyphenyl)pyridine
AA00D8BZ | MFCD06802137
500884-43-5
500884-43-5
3-(2-Methoxyphenoxy)benzoic acid
AA00D8GF | MFCD03840108
520-28-5
520-28-5
Tectochrysin
AA00D8M9 | MFCD00016945
444343-55-9
444343-55-9
Potassium butyltrifluoroborate
AA00D8SU | MFCD08276805
5440-17-5
5440-17-5
6-Chloro-7-methyl-7H-purine
AA00D8XE | MFCD01943043
53132-08-4
53132-08-4
4-Ethoxyphenyl 4-propylbenzoate
AA00D92Y | MFCD11053416
436100-02-6
436100-02-6
5-(tert-Butyl)-2-((diethylamino)methyl)furan-3-carboxylic acid
AA00D99X | MFCD03034337
436096-79-6
436096-79-6
N-(4-Ethylbenzyl)-n-(pyridin-3-ylmethyl)amine
AA00D9GA | MFCD03446304
48150-45-4
48150-45-4
3-Methacrylamidophenylboronic acid
AA00D9OA | MFCD09475805
Historical Records
862827-01-8
862827-01-8
Submit
© 2017 AA BLOCKS, INC. All rights reserved.